23 May 2013
Keywords: rebetron, indications, expanded, into, hcv, schering-plough, ribavirin
Article | 16 December 1998
Schering-Plough's Rebetron (ribavirin and interferon alfa-2b) has beenapproved in the USA for a new indication, the treatment of chronic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.